Literature DB >> 11905511

Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box.

E G Bliznakov1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11905511     DOI: 10.1016/s0753-3322(01)00150-0

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


× No keyword cloud information.
  5 in total

Review 1.  LDL-C-lowering therapy: current and future therapeutic targets.

Authors:  Maartje E Visser; Lily Jakulj; John J P Kastelein; Erik S G Stroes
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

2.  Selection of Cholesterol-Lowering Lactic Acid Bacteria and its Effects on Rats Fed with High-Cholesterol Diet.

Authors:  Yufang Liu; Fengchun Zhao; Jiye Liu; Huimin Wang; Xiao Han; Yongxin Zhang; Zhengyou Yang
Journal:  Curr Microbiol       Date:  2017-03-13       Impact factor: 2.188

Review 3.  Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.

Authors:  Manoj Kumar; Ravinder Nagpal; Rajesh Kumar; R Hemalatha; Vinod Verma; Ashok Kumar; Chaitali Chakraborty; Birbal Singh; Francesco Marotta; Shalini Jain; Hariom Yadav
Journal:  Exp Diabetes Res       Date:  2012-05-03

4.  Microencapsulated Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol.

Authors:  Mitchell Lawrence Jones; Hongmei Chen; Wei Ouyang; Terrence Metz; Satya Prakash
Journal:  J Biomed Biotechnol       Date:  2004

5.  Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial.

Authors:  Hoda Zahedi; Shahryar Eghtesadi; Soroush Seifirad; Neshat Rezaee; Farzad Shidfar; Iraj Heydari; Banafsheh Golestan; Shima Jazayeri
Journal:  J Diabetes Metab Disord       Date:  2014-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.